Yoo J, Manicone A M, McGuire J K, et al. Systemic sensitization with the protein allergen ovalbumin augments local sensitization in atopic dermatitis[J]. J Inflamm Res, 2014, 7(2):29-38.
[3]
Yoo J, Manicone A M, McGuire J K, et al. Systemic sensitization with the protein allergen ovalbumin augments local sensitization in atopic dermatitis[J]. J Inflamm Res, 2014, 7(2):29-38.
[4]
Oshio T, Sasaki Y, Funakoshi-Tago M, et al. Dermatophagoides farinae extract induces severe atopic dermatitis in NC/Nga mice, which is effectively suppressed by the administration of tacrolimus ointment[J]. Int Immunopharmacol, 2009, 9(4):403-411.
Oshio T, Sasaki Y, Funakoshi-Tago M, et al. Dermatophagoides farinae extract induces severe atopic dermatitis in NC/Nga mice, which is effectively suppressed by the administration of tacrolimus ointment[J]. Int Immunopharmacol, 2009, 9(4):403-411.
Choi J H, Park B H, Kim H G, et al. Inhibitory effect of Psidium guajava water extract in the development of 2, 4-dinitrochlorobenzene-induced atopic dermatitis in NC/Nga mice[J]. Food Chem Toxicol, 2012, 50(8):2923-2929.
[7]
Choi J H, Park B H, Kim H G, et al. Inhibitory effect of Psidium guajava water extract in the development of 2, 4-dinitrochlorobenzene-induced atopic dermatitis in NC/Nga mice[J]. Food Chem Toxicol, 2012, 50(8):2923-2929.
Yano S, Umeda D, Yamashita S, et al. Dietary apigenin attenuates the development of atopic dermatitis-like skin lesions in NC/Nga mice[J]. J Nutr Biochem, 2009, 20(11):876-881.
[9]
Yano S, Umeda D, Yamashita S, et al. Dietary apigenin attenuates the development of atopic dermatitis-like skin lesions in NC/Nga mice[J]. J Nutr Biochem, 2009, 20(11):876-881.
[10]
Hatano Y, Man M Q, Uchida Y, et al. Murine atopic dermatitis responds to peroxisome proliferatoractivated receptor α, β/△(but not γ), and liver-X-receptor activators[J]. J Allergy Clin Immunol, 2010, 125(1):1-5.
[10]
Hatano Y, Man M Q, Uchida Y, et al. Murine atopic dermatitis responds to peroxisome proliferatoractivated receptor α, β/△(but not γ), and liver-X-receptor activators[J]. J Allergy Clin Immunol, 2010, 125(1):1-5.
[11]
Tanaka A, Amagai Y, Oida K, et al.Recent findings in mouse models for human atopic dermatitis[J]. Exp Anim, 2012, 61(2):77-84.
[11]
Tanaka A, Amagai Y, Oida K, et al.Recent findings in mouse models for human atopic dermatitis[J]. Exp Anim, 2012, 61(2):77-84.
[12]
Mitsuishi T, Kabashima K, Tanizaki H, et al. Specific substance of Maruyama (SSM) suppresses immune responses in atopic dermatitis-like skin lesions in DS-Nh mice by modulating dendritic cell functions[J]. J Dermatol Sci, 2011, 63(3):184-190.
[12]
Mitsuishi T, Kabashima K, Tanizaki H, et al. Specific substance of Maruyama (SSM) suppresses immune responses in atopic dermatitis-like skin lesions in DS-Nh mice by modulating dendritic cell functions[J]. J Dermatol Sci, 2011, 63(3):184-190.
[13]
Oyoshi M K, Murphy G F. Filaggrin deficient mice exhibit Th17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen[J]. J Allergy Clin Immunol, 2009, 124(3):485-493.
[13]
Oyoshi M K, Murphy G F. Filaggrin deficient mice exhibit Th17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen[J]. J Allergy Clin Immunol, 2009, 124(3):485-493.
[14]
Nakajima S, Kitoh A, Egawa G, et al. IL-17A as an Inducer for Th2 Immune Responses in Murine Atopic Dermatitis Models[J]. J Invest Dermatol, 2014, 134(8):2122-2130.
[14]
Nakajima S, Kitoh A, Egawa G, et al. IL-17A as an Inducer for Th2 Immune Responses in Murine Atopic Dermatitis Models[J]. J Invest Dermatol, 2014, 134(8):2122-2130.
[15]
Sasaki T, Shiohama A, Kubo A , et al. A homozygous nonsense mutation in the gene for Tmem79, a component for the lamellar granule secretory system, produces spontaneous eczema in an experimental model of atopic dermatitis[J]. J Allergy Clin Immunol, 2013, 132(5):1111-1120.
[15]
Sasaki T, Shiohama A, Kubo A , et al. A homozygous nonsense mutation in the gene for Tmem79, a component for the lamellar granule secretory system, produces spontaneous eczema in an experimental model of atopic dermatitis[J]. J Allergy Clin Immunol, 2013, 132(5):1111-1120.
[16]
Chan L S, Robinson N, Xu L.Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis[J].J Invest Dermatol, 2001, 117(4):977-83.
[16]
Chan L S, Robinson N, Xu L.Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis[J].J Invest Dermatol, 2001, 117(4):977-83.
[17]
Oh M H, Oh S Y, Yu J, et al. IL-13 induces skin fibrosis in atopic dermatitis by thymic stromal lymphopoietin[J]. J Immunol, 2011, 186(12):7232-7242.
[17]
Oh M H, Oh S Y, Yu J, et al. IL-13 induces skin fibrosis in atopic dermatitis by thymic stromal lymphopoietin[J]. J Immunol, 2011, 186(12):7232-7242.
[18]
Darling A R, Freyschmidt E J, Burton O T , et al.IL-10 suppresses IL-17-mediated dermal inflammation and reduces the systemic burden of Vaccinia virus in a mouse model of eczema vaccinatum[J].Clin Immunol, 2014, 150(2):153-60.
[18]
Darling A R, Freyschmidt E J, Burton O T , et al.IL-10 suppresses IL-17-mediated dermal inflammation and reduces the systemic burden of Vaccinia virus in a mouse model of eczema vaccinatum[J].Clin Immunol, 2014, 150(2):153-60.
[19]
Dillon S R, Sprecher C, Hammond, et al. AInterleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice[J]. Nat Immunol, 2004, 5(7):752-760.
[19]
Dillon S R, Sprecher C, Hammond, et al. AInterleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice[J]. Nat Immunol, 2004, 5(7):752-760.
[20]
Yoo J, Omori M, Gyarmati D, et al. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin[J]. J Exp Med, 2005, 202(4):541-549.
[20]
Yoo J, Omori M, Gyarmati D, et al. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin[J]. J Exp Med, 2005, 202(4):541-549.
[21]
Kim N, Bae K B, Kim M O, et al. Overexpression of cathepsin S induces chronic atopic dermatitis in mice. [J]. J Invest Dermatol, 2012, 132(4):1169-1176.
[21]
Kim N, Bae K B, Kim M O, et al. Overexpression of cathepsin S induces chronic atopic dermatitis in mice. [J]. J Invest Dermatol, 2012, 132(4):1169-1176.
[22]
Nagelkerken L, Verzaal P, Lagerweij T , et al. Development of atopic dermatitis in mice transgenic for human apolipoprotein C1[J]. J Invest Dermatol, 2008, 128(5):1165-1172.
[22]
Nagelkerken L, Verzaal P, Lagerweij T , et al. Development of atopic dermatitis in mice transgenic for human apolipoprotein C1[J]. J Invest Dermatol, 2008, 128(5):1165-1172.
[23]
Tsukuba T, Okamoto K, Okamoto Y, et al. Association of cathepsin E deficiency with development of atopic dermatitis[J]. J Biochem, 2003, 134(6):893-902.
[23]
Tsukuba T, Okamoto K, Okamoto Y, et al. Association of cathepsin E deficiency with development of atopic dermatitis[J]. J Biochem, 2003, 134(6):893-902.
2015, Vol. 26 
